Gastritis + PUD + Gastric CA Flashcards

1
Q

What are some normal damaging forces and some normal defensive forces of the stomach?

A

Damaging:
Gastric Acidity
Peptic Enzymes

DEFENSIVE:
Surface Mucous secretion
Bicarb Secretion
Mucosal blood flow
apical surface membrane transport
epithelial regenerative capacity
elaboration of prostaglandins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes acute gastritis. Explain. Describe various risk factors. What is the pathological result?

A

A C U T E G A S T R I T I S
A. Acidic damag e to the stomac h mucos a

B . Due to imbalanc e between mucosal defenses and acidic environment
1 . Defenses include muci n layer produced by foveolar cells, bicarbonate secretion b y surface epithelium, and normal blood supply (provides nutrients and picks up
leaked acid).

C. Risk factors
1 . Severe burn (Curling ulcer) — Hypovolemia leads to decreased blood supply.
2. NSAID s (decreased PGE. )
3 . Heavy alcohol consumptio n
4. Chemotherap y
5 . Increased intracranial pressure (Cushing ulcer)—Increased stimulatio n of vagus
nerve leads to increased acid production.
6. Shock—Multiple (stress) ulcers may be seen in 1CU patients.

D. Acid damag e results in superficial inflammation, erosion (loss of superficial epithelium), or ulcer (loss of mucosal layer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is chronic gastritis? What are 2 categories of Chronic Gastritis?

A

A. Chroni c Inflammatio n of stomach mucosa

B . Divided into two types based on underlying etiology: chronic autoimmune gastritis
and chronic H pylori gastritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes chronic autoimmune gastritis? Where is the damage? What is the pathogenesis? Clinical/physiological features? How is the diagnosis made? Microscopic features?

A

Chronic autoimmune gastritis is due to autoimmun e destructio n of gastric parietal cells, which are located in the stomach body and fundus .
1 . Associated with antibodies against parietal cells and/o r intrinsic factor; useful for diagnosis, but pathogenesis is mediated by T cells (type IV hypersensitivity)

2, Clinical features

i. Atrophy of mucos a with intestinal metaplasia (Fig. 10.11)
ii. Achlorhydria with increased gastrin levels and antral G-cell hyperplasia
iii. Megaloblastic (pernicious) anemia due to lack of intrinsic factor (vit. b12 defiency)
iv. Increased risk tor gastric adenocarcinoma (intestinal type)

MICROSCOPIC
Loss of parietal cells

Loss of glands (atrophy)

Intestinal metaplasia,
pseudopyloric metaplasia,
and endocrine cell
hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the pathogenesis of chronic h. pylori gastritis? Where is it located? Microscopic pathology? How common is it? How does it present? What is the treatment? How effective is it? How do you know if its working?

A

Antrum

Spiral-shaped H. pylori are highlighted in this
Warthin-Starrysilver stain

Intraepithelial and lamina propria neutrophils

Lymphoid aggregates with germinal centers

subepithelial plasma cells within the superficial
lamina propria

Chroni c H pylori gastritis is due to H pylori-induced acute and chronic inflammation; mos t c o m m o n form of gastritis (90%)
1 . H pylori ureases and proteases along with inflammatio n weaken mucosal
defenses; a n t r u m is the most commo n site (Fig. 10.12),
2. Presents with epigastric abdominal pain; increased risk for ulceration (peptic
ulcer disease), gastric adenocarcinoma (intestinal type), and MALT lymphoma

3 . Treatment involves triple therapy (PPI, clarithromycin, amoxicyllin).

i. Resolves gastritis/ulcer and reverses intestinal metaplasia
ii. Negative urea breath test and lack of stool antigen confirm eradication of H pylori.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are two hypertrophic gastropathies?

A

Menetrier?s Disease

Zollinger-Ellison syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Menetriers disease.

A

Hypoproteinemia due to protein-losing enteropathy

Diffuse hyperplasia of the foveolar
epithelium of the body and fundus

Caused by excessive
secretion of
transforming growth
factor a (TGF-a)

Glandular atrophy is typical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe Zollinger Ellison Syndrome.

A

Caused by gastrinoma in the
small bowel or pancreas

Presented with duodenal ulcers
or chronic diarrhea

Doubling of oxyntic mucosal
thickness due to fivefold
increase in the number of
parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a gastric CA? What are the 2 subclassifications? How does it present? To which lymph nodes does it spread? What does it metastasize? What are two pathogeneses and which subclassification are they associated with?

A

A. Malignant proliferation of surface epithelial cells (adenocarcinoma)
B. Subclassilied into intestinal and diffuse types

o The loss of E-cadherin (encoded by CDH1 gene) function seems to be a key step in the development of diffuse gastric cancer

o Mutation in β-catenin (a protein binds to both E-cadherin and APC), microsatellite instability and hypermethylation of several genes are involved in sporadic intestinal-type gastric cancer.

E. Gastric carcinoma presents late with weight loss, abdominal pain, anemia, and early satiety; rarely presents as acanthosis nigricans or Leser-Trelat sign

F. Spread to lymph nodes can involve the left supraclavicular node (Virchow node).

G. Distant metastasis most commonl y involves liver; other sites include:
I. Periumbilical region (Sister Mary Joseph nodule); seen with intestinal type
2.Bilateral ovaries (Krukenberg tumor) ; seen with diffuse type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe Diffuse type gastric CA both grossly and microscopically. What is it not associated with?

A

D. Diffus e typ e is characterized by signet ring cells that diffusely inliltrate the gastric wall (Fig. 10.14B); desmoplasia results in thickening of stomach wall (linitis plasties, Fig, 10.I4A).
1 , Not associated with H pylori, intestinal metaplasia, or nitrosamine s

Signet-ring cells: large cytoplasmic mucin vacuoles and peripherally displaced, crescent-shaped nuclei.?

LINITIS PLASTICA
markedly thickened gastric wall and partially lost rugal folds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the more common gastric CA type? How does it present? Where is it most commonly? What are the risk factors?

A

C. Intestinal typ e (more common) presents as a large, irregular ulcer with heaped up
margins; most commonl y involves the lesser curvature of the a n t r u m (similar to
gastric ulcer)
1 . Risk factors include intestinal metaplasia (e.g., due to H pylori and autoimmune gastritis), nitrosamines in smoked foods (Japan), and blood typ e A.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some examples of neoplastic gastric polyps? Non-neoplastic?

A

Neoplastic
Adenoma

Non-neoplastic

Hyperplastic polyp
? Is there any 
dysplasia
Elongated dilated 
foveolae

Fundic gland polyp
Sporadic vs FAP
Dilated oxyntic glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a MALToma?

A

MALToma (Mucosal associated lymphoid

tissue lymphoma). Associated with H. Pylori chronic gastritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a peptic ulcer? Where does it occur? What is most common? What are peptic ulcers? What are the symptoms? compare and contrast duodenal and gastric ulcers. What are some alarm symptoms?

A

A. Solitary mucosal ulcer involving proximal duodenum (90%) or distal stomach (10%)

Defects or breaks in the mucousa with depth and have
extended through muscularis mucousa

Epigastric pain ? ?dull, aching, hunger like,
empty?

Duodenal ulcer-relieved with ingestion of
milk, food, antacids, recurs 2-4 hours later or
at night

Gastric ulcers-eating makes symptoms worse

Alarm symptoms: acute change in pain, overt
GI bleeding, anemia, weight loss, vomiting,
early satiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a duodenal ulcer most likely due to? What else might it be due to? How does it present? What is seen on biopsy? What are the complications?

A

B. Duodenal ulcer is almost always due to H pylori (> 95%); rarely, may be due to ZE syndrome
! , Presents with epigastric pain that improves with meals
2. Diagnostic endoscopic biopsy shows ulcer with hypertrophy of Brunne r glands .
3 . May rupture leading to bleeding fro m the gastroduodenal artery (posterior) or acute pancreatitis (posterior ulcer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a gastric ulcer usually due to? What are some other causes? How does it present? Where is it located? What are its complications?

A

C. Gastric ulcer is usually due to H pylori (75%); other causes include NSAlD s and bile
reflux.
1 . Presents with epigastric pain that worsens with meals
2. Ulcer is usually located on the lesser curvature ol the antrum .
3 . Rupture carries risk of bleeding from left gastric artery.

17
Q

Explain a few principles that help determine if an ulcer is malignant.

A

D. Differential diagnosis of ulcers includes carcinoma.
1 , Duodenal ulcers are almost never malignant (duodenal carcinoma is extremely
rare).
2. Gastric ulcers can be caused by gastric carcinoma (intestinal subtype).
i. Benign peptic ulcers are usually small (< 3 cm), sharply demarcated(“punched-out”) , and surrounde d by radiating folds of mucosa (Fig. 10.13A).
ii. Malignant ulcers are large and irregular with heaped up margins (Fig.10.13B)
iii. Biopsy is required for definitive diagnosis.

18
Q

What is H. Pylori? How does it lead to PUD? What else does it lead to? When is it acquired? What are some risk factors?

A

Gram negative urease producing bacteria

Urease production helps alkalinize mucousa

Usually acquired in childhood

Risk factors: low socioeconomic status,
crowding, country of origin (developing)

Most asymptomatic : 10-15% develop ulcers

Carcinogen: Gastric adenocarcinoma, MALT

Increased risk of PUD and GI bleeding (3-7
fold)

Present in 70-90% of duodenal ulcers

30-60% of gastric ulcers

Eradication of h.pylori reduces recurrence of
ulcers

19
Q

How does NSAIDS/Aspirin use lead to PUD?

A

15-30% of patients using these drugs develop
PUD

RR peptic ulcer disease 3-10x higher vs. no
exposure

Inhibition of COX-1 impairs mucousal
protection by decreasing prostaglandin
synthesis

20
Q

Describe various pathogeneses of PUD. List 4 other risk factors.

A

Multi-factorial

Imbalance
Gastric acid/pepsin>Gastric mucousal defenses

Helicobacter pylori

Medications: NSAIDS/Aspirin
Inhibit cyclo-oxygenase (COX 1 and COX2)

Infections

Cancer or other rare disorders

3-5% gastric ulcers associated with malignancy

<1% of duodenal ulcers associated with ZE syndrome

OTHER RISK FACTORS

Smoking-impaired mucousal blood flow
and healing

Stress/Critically ill patients (severe burn
patients, physical trauma, multiple organ
failure)

Corticosteroids -suppress prostaglandin
synthesis and impair healing

Hypercalcemia stimulates gastrin

21
Q

In which pts. do stress ulcers occur? What are the ulcers like? What is the etiology? Risk factors? How can they be prevented?

A

Critically ill patients, Head/SCI trauma
(Cushing), Burn (Curling)

Diffuse bleeding from erosions and
superficial ulcers

Etiology due to decreased mucousal
protection and mucousal ischemia

Risk factors: coagulopathy, mechanical
ventilation > 48 hours

Prevent: H2RA or PPI

22
Q

What are some complications of PUD?

A

GI bleeding- 15%
Most frequent complications
~25% of ulcer deaths due to bleeding

Obstruction - <2%
Due to edema/scarring

Pylori channel ulcers

Perforation/Penetration- 7%

Mortality Rate 10%

23
Q

What steps should be taken for diagnosing PUD?

A

Test and treat for hpylori

Treat with acid suppression and monitor Sx

Evaluate with EGD

Refractory symptoms

Alarm symptoms

24
Q

What steps should be taken for treating PUD?

A

Heal ulcer
Use of acid suppression

Prevent recurrence
Test for h.pylori
Evaluate for NSAID use

25
Q

When should surgery be performed in PUD? What surgeries?

A

Refractory to medical therapy
Life-threatening complications

Vagotomy with drainage procedure (pyloroplasty)
Partial gastrectomy, Bilroth 1 or 2 anatomy
Oversew the ulcer, omental patch
Angiography-coils, gels, microspheres, etc

26
Q

Describe the pathology/pathogenesis of ZE syndrome. When should it be suspected?

A

Gastrin secreting endocrine tumor
(gastrinoma)

5 fold increase in parietal cell mass->
Marked gastric acid hypersecretion

Solitary tumors in 75% in SI/pancreas

Peptic ulcer disease (0.1-1%)

Chronic diarrhea

Diagnosis: increased gastrin,EUS/octreotide scan

Middle aged man
Acid is the mechanism
Large duodenal ulcer
Esophagitis and ulcers
Ulcers in unusual locations (second 
duodenum/jejunum)
Refractory ulcers
Ulcers with hypercalcemia
Ulcers and diarrhea
27
Q

What is MEN 1? When does it occur? What is it? Treatment?

A

Autosomal dominant

Tumors of the 3 P?s

Parathyroid, pancreatic, pituitary

Pancreatic tumor most common
(gastrinoma>insulinoma)

Gastrinomas usually multiple

May benefit from treatment with somatostatin receptors,
interferon, chemoembolization,chemotherapy

Surgery controversial: indolent course, multiple tumors